Exjade and Arterial disorder - a phase IV clinical study of FDA data

Among these 24 people:

How long have people been on Exjade when they have Arterial disorder? *

• < 1 month: 0.0 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 0.0 %
• 2 - 5 years: 100 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

What is the gender of people who have Arterial disorder when taking Exjade? *

• female: 33.33 %
• male: 66.67 %

What is the age of people who have Arterial disorder when taking Exjade? *

• 0-1: 0.0 %
• 2-9: 4.35 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 0.0 %
• 40-49: 17.39 %
• 50-59: 60.87 %
• 60+: 17.39 %

What are other drugs people take besides Exjade? *

1. Norvasc: 15 people, 62.50%
2. Altace: 14 people, 58.33%
3. Penlac: 14 people, 58.33%
4. Oxazepam: 14 people, 58.33%
5. Nexium: 14 people, 58.33%
6. Ativan: 14 people, 58.33%
7. Crestor: 14 people, 58.33%
8. Aspirin: 10 people, 41.67%
9. Atenolol: 10 people, 41.67%
10. Perindopril Erbumine: 7 people, 29.17%

What are other side effects people have besides Arterial disorder? *

1. Abdominal Discomfort: 18 people, 75.00%
2. Rashes (redness): 14 people, 58.33%
3. Nausea And Vomiting: 14 people, 58.33%
4. Pharyngitis (inflammation of the pharynx, causing a sore throat): 13 people, 54.17%
5. Chest Pain: 12 people, 50.00%
6. Malaise (a feeling of general discomfort or uneasiness): 12 people, 50.00%
7. Haemorrhage (bleeding): 11 people, 45.83%
8. Nausea (feeling of having an urge to vomit): 7 people, 29.17%
9. Itching: 7 people, 29.17%
10. Lacrimation Increased: 6 people, 25.00%

What are the existing conditions these people have? *

1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 14 people, 58.33%
2. Psoriasis (immune-mediated disease that affects the skin): 7 people, 29.17%
3. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 4.17%
4. Haemolytic Anaemia (anaemia due to haemolysis): 1 person, 4.17%
5. Haemochromatosis (body to absorb more iron than usual from food): 1 person, 4.17%
6. Fever: 1 person, 4.17%
7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.17%

Do you take Exjade and have Arterial disorder?

- Check whether Arterial disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

---

---

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exjade:

Arterial disorder treatments and more:

How severe was Arterial disorder and when was it recovered:

• Arterial disorder in Exjade

Expand to all the drugs that have ingredients of deferasirox:

• Arterial disorder and drugs with ingredients of deferasirox

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

• Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
• Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
• Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
• Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
• Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
• Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
• Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
• Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
• Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
• Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .

---

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

---

---

Recent studies on eHealthMe:

• Could Celebrex cause Nephritis? - 5 seconds ago
• Could Arthrotec cause Multiple Sclerosis? - 6 seconds ago
• Psychotic Disorder and Mood Swings - 11 seconds ago
• Could Liver cause Dry Eyes? - 13 seconds ago
• Hiv Test Positive and Itching - 14 seconds ago
• Sleep Disorder and Wound Infection - 15 seconds ago
• Could Septra cause Bone Pain? - 17 seconds ago
• Drug interactions of Norflex and Lipitor - 22 seconds ago
• Bowel Movement Irregularity and Urination - Excessive At Night - 31 seconds ago
• Drug interactions of Detrol and Docetaxel - 35 seconds ago